The drugmaker filed a lawsuit saying Medicare’s drug-price negotiation program violates the company’s constitutional rights.
The company is heavily reliant on a cancer drug that could be targeted by a program intended to lower drug prices.
A new report projects that economic growth will slow this year and remain weak in 2024.
The bank warned of risks to poorer nations from rising interest rates.
Some additional policy support now looks likely for China’s housing market. But a lackluster recovery is still the most probable outcome.
Officials are seeking a court order to block online dissemination of a popular pro-democracy anthem, in the first major test for U.S. tech platforms over politically sensitive content.
Republicans hope to revive expired business tax breaks in a bill they could introduce this month.
The regulator said the U.S.’s largest crypto platform violated rules that require it to register as an exchange.
The regulator said that the cryptocurrency trading platform allowed users to trade unregistered securities, a day after it accused the crypto platform Binance of mishandling funds.
The CEO says green subsidies in the U.S. mean its fourth factory attempt could be the charm.